Conjugation of hydroxyethyl starch to desferrioxamine (DFO) modulates the dual role of DFO in Yersinia enterocolitica infection

Clinical and Diagnostic Laboratory Immunology

Volumn 7, Issue 3, 2000, Pages 457-462

  Schubert, Sören ^a   Autenrieth, Ingo B ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEFEROXAMINE; HETASTARCH;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CYTOKINE PRODUCTION; FEMALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; YERSINIA ENTEROCOLITICA;

ANIMALS; CELL DIVISION; CHELATING AGENTS; DEFEROXAMINE; DRUG COMPOUNDING; HETASTARCH; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMA SUBSTITUTES; T-LYMPHOCYTES; VIRULENCE; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 0034064345     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.7.3.457-462.2000     Document Type: Article

References (47)

1. Allain, P., Y. Mauras, D. Chaleil, P. Simon, K. S. Ang, G. Cam, L. Le Mignon, and M. Simon. 1987. Pharmakokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis. Br. J. Clin. Pharmacol. 24:207-212.
2. Autenrieth, I. B., M. Beer, E. Bohn, S. H. Kaufmann, and J. Heesemann. 1994. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect. Immun. 62:2590-2599.
3. Autenrieth, I. B., E. Bohn, J. H. Ewald, and J. Heesemann. 1995. Deferoxamine B but not deferoxamine G1 inhibits cytokine production in murine bone marrow macrophages. J. Infect. Dis. 172:490-496.
4. Autenrieth, I. B., K. Hantke, and J. Heesemann. 1991. Immunosuppression of the host and delivery of iron to the pathogen: a possible dual role of siderophores in the pathogencsis of microbial infections? Med. Microbiol. Immunol. 180:135-141.
5. Autenrieth, I. B., R. Reisbrodt, E. Saken, R. Berner, U. Vogel, W. Rabsch, and J. Heesemann. 1994. Desferrioxamine-promoted virulence of Yersinia enterocolitica for mice depends on both desferrioxamine species and mouse strains. J. Infect. Dis. 169:562-567.
6. Autenrieth, I. B., A. Tingle, A. Reske Kunz, and J. Heesemann. 1992. T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect. Immun. 60:1140-1149.
7. Autenrieth, I. B., U. Vogel, S. Preger, B. Heymer, and J. Heesemann. 1993. Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response. Infect. Immun. 61:2585-2595.
8. Bagg, A., and J. B. Neilands. 1987. Molecular mechanism of regulation of siderophore-mediated iron assimilation. Microbiol. Rev. 51:509-518.
9. Baron, J. F. 1992. Pharmacology of low molecular weight hydroxyethyl starch. Ann. Fr. Anesth. Reanim. 11:509-515. (In French.)
10. Baumler, A., R. Koebnik, I. Stojiljkovic, J. Heesemann, V. Braun, and K. Hantke. 1993. Survey on newly characterized iron uptake systems of Yersinia enterocolitica. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 278:416-424.
11. Bäumler, A. J., and K. Hantke. 1992. Ferrioxamine uptake in Yersinia enterocolitica: characterization of the receptor protein FoxA. Mol. Microbiol. 6:1309-1321.
12. Bearden, S. W., J. D. Fetherston, and R. D. Perry. 1997. Genetic organization of the yersiniabactin biosynthetic region and construction of avirulent mutants in Yersinia pestis. Infect. Immun. 65:1659-1668.
13. Boelaert, J. R., M. de Locht, J. Van Cutsem, V. Kerrels, B. Cantinieaux, A. Verdonck, H. W. van Landuyt, and Y. J. Schneider. 1993. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J. Clin. Investig. 91:1979-1986.
14. Bottomley, S. S., L. C. Wolfe, and K. R. Bridges. 1985. Iron metabolism in K562 erythroleukemic cells. J. Biol. Chem. 260:6811-6815.
15. Boyce, N., C. Wood, S. Holdsworth, N. M. Thomson, and R. C. Atkins. 1985. Life-threatening sepsis complicating heavy metal chelation therapy with desferrioxamine. Aust. N. Z. J. Med. 15:654-655.
16. Braun, V., and K. Hantke. 1991. Genetics of bacterial iron transport, p. 107-138. In G. Winkelmann (ed.), Handbook of microbial iron chelates. CRC Press, Inc., Boca Raton, Fla.
17. Braun, V., and G. Winkelmann. 1987. Microbial iron transport: structure and function of siderophores. Prog. Clin. Biochem. Med. 5:67-99.
18. Bullen, J. J., and E. Griffiths. 1987. Iron and infection, p. 69-137. John Wiley and Sons, Chichester, United Kingdom.
19. Crosa, J. H. 1989. Genetics and molecular biology of siderophore-mediated iron transport in bacteria. Microbiol. Rev. 53:517-530.
20. Deiss, K., K. Hantke, and G. Winkelmann. 1998. Molecular recognition of siderophores: a study with cloned fcrrioxamine receptors (FoxA) from Erwinia herbicola and Yersinia enterocolitica. Biometals 11:131-137.
21. Ewald, J. H., J. Heesemann, H. Rüdiger, and I. B. Autenrieth. 1994. Interaction of polymorphonuclear leukocytes with Yersinia enterocolitica: role of the Yersinia virulence plasmid and modulation by the iron-chelator desferrioxamine B. J. Infect. Dis. 170:140-150.
22. Hallaway, P. E., J. W. Eaton, S. S. Panter, and B. E. Hedlund. 1989. Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc. Natl. Acad. Sci. USA 86:10108-10112.
23. Heesemann, J. 1987. Chromosomal-encoded siderophores are required for mouse virulence of enteropathogenic Yersinia species. FEMS Microbiol. Lett. 48:229-233.
24. Heesemann, J., K. Hantke, T. Vocke, E. Saken, A. Rakin, I. Stojiljkovic, and R. Berner. 1993. Virulence of Yersinia enterocolitica is closely associated with siderophore production, expression of an iron-repressible outer membrane protein of 65000 Da and pesticin sensitivity. Mol. Microbiol. 8:397-408.
25. Hoogkamp Korstanje, J. A., J. de Koning, and J. Heesemann. 1988. Persistence of Yersinia enterocolitica in man. Infection 16:81-85.
26. Hoyes, K. P., and J. B. Porter. 1993. Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools. Br. J. Haematol. 85:393-400.
27. Kelly, D. A., E. Price, B. Jani, V. Wright, M. Rossiter, and J. A. Walker Smith. 1987. Yersinia enterocolitis in iron overload. J. Pediatr. Gastroenterol. Nutr. 6:643-645.
28. Larsen, J. H. 1979. The spectrum of clinical manifestations of infections with Yersinia enterocolitica and their pathogenesis. Contrib. Microbiol. Immunol. 5:257-269.
29. Mahoney, J. R., Jr., P. E. Hallaway, B. E. Hedlund, and J. W. Eaton. 1989. Acute iron poisoning. Rescue with macromolecular chelators. J. Clin. Investig. 84:1362-1366.
30. Moch, D., B. Schroppel, M. H. Schoenberg, H. J. Schulz, F. C. Thorab, M. Marzinzag, B. E. Hedlund, and U. B. Bruckner. 1995. Protective effects of hydroxyethyl starch-deferoxamine in early sepsis. Shock 4:425-432.
31. Modell, B. 1979. Advances in the use of iron-chelating agents for the treatment of iron overload. Prog. Hematol. 11:267-312.
32. Mousa, S. A., R. C. Ritger, and R. D. Smith. 1992. Efficacy and safety of deferoxamine conjugated to hydroxyethyl starch. J. Cardiovasc. Pharmacol. 19:425-429.
33. Paitel, J. F., A. P. Guerci, V. Dorvaux, and P. Lederlin. 1995. Yersinia enterocolitica septicemia, iron overload and deferoxamine. Rev. Med. Interne 16:705-707. (In French.)
34. Paller, M. S., and B. E. Hedlund. 1994. Extracellular iron chelators protect kidney cells from hypoxia/reoxygenation. Free Radic. Biol. Med. 17:597-603.
35. Pelludat, C., A. Rakin, C. A. Jacobi, S. Schubert, and J. Heesemann. 1998. The yersiniabactin biosynthetic gene cluster of Yersinia enterocolitica: organization and siderophore-dependent regulation. J. Bacteriol. 180:538-546.
36. Perry, R. D., and R. R. Brubaker. 1979. Accumulation of iron by yersiniae. J. Bacteriol. 137:1290-1298.
37. Rabson, A. R., A. F. Hallett, and H. J. Koornhof. 1975. Generalized Yersinia enterocolitica infection. J. Infect. Dis. 131:447-451.
38. Rakin, A., P. Urbitsch, and J. Heesemann. 1995. Evidence for two evolutionary lineages of highly pathogenic Yersinia species. J. Bacteriol. 177:2292-2298.
39. Robins-Browne, R. M., and J. K. Prpic. 1983. Desferrioxamine and systemic yersiniosis. Lancet ii:1372.
40. Robins-Browne, R. M., and J. K. Prpic. 1985. Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect. Immun. 47:774-779.
41. Roza, A. M., D. P. Slakey, G. M. Pieper, T. M. Van Ye, G. Moore Hilton, R. A. Komorowski, C. P. Johnson, B. E. Hedlund, and M. B. Adams. 1994. Hydroxyethyl starch deferoxamine, a novel iron chelator, delays diabetes in BB rats. J. Lab. Clin. Med. 123:556-560.
42. Saito, K., H. Yoshioka, N. Ito, S. Kazama, H. Tanizawa, Y. Lin, H. Watanabe, T. Ogata, and H. Kamada. 1997. Spatiotemporal ESR-CT study on the metabolism of spin-labeled polysaccharide in a mouse. Biol. Pharm. Bull. 20:904-909.
43. Sauer, M., K. Hantke, and V. Braun. 1987. Ferric-coprogen receptor FhuE of Escherichia coli: processing and sequence common to all TonB-dependent outer membrane receptor proteins. J. Bacteriol. 169:2044-2049.
44. Sauer, M., K. Hantke, and V. Braun. 1990. Sequence of the fhuE outer-membrane receptor gene of Escherichia coli K12 and properties of mutants. Mol. Microbiol. 4:427-437.
45. Schaeffer, R. C., Jr., R. R. Renkiewicz, S. M. Chilton, D. Marsh, and R. W. Carlson. 1986. Preparation and high-performance size-exclusion Chromatographic (HPSEC) analysis of fluorescein isothiocyanate-hydroxyethyl starch: macromolecular probes of the blood-lymph barrier. Microvasc. Res. 32:230-243.
46. Slade, S. J., and J. Langhorne. 1989. Production of interferon-gamma during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology 179: 353-365.
47. Weinberg, E. D. 1984. Iron withholding: a defense against infection and neoplasia. Physiol. Rev. 64:65-102.